| 000 | 02049nam a2200469 i 4500 | ||
|---|---|---|---|
| 001 | EBC5294185 | ||
| 003 | MiAaPQ | ||
| 006 | m o d | | ||
| 007 | cr cnu|||||||| | ||
| 008 | 180310t20182018vaua ob 001 0 eng d | ||
| 020 | _z9781615370832 | ||
| 020 | _a9781615371709 (e-book) | ||
| 035 | _a(MiAaPQ)EBC5294185 | ||
| 035 | _a(Au-PeEL)EBL5294185 | ||
| 035 | _a(CaPaEBR)ebr11512268 | ||
| 035 | _a(OCoLC)1024284552 | ||
| 040 |
_aMiAaPQ _beng _erda _epn _cMiAaPQ _dMiAaPQ |
||
| 050 | 4 |
_aRC568.O45 _b.O345 2018 |
|
| 082 | 0 |
_a615/.7822 _223 |
|
| 245 | 0 | 0 |
_aOffice-based buprenorphine treatment of opioid use disorder / _cedited by John A. Renner Jr., M.D., Petros Levounis, M.A., Anna T. LaRose, M.D. |
| 250 | _aSecond edition. | ||
| 264 | 1 |
_aArlington, Virginia : _bAmerican Psychiatric Association Publishing, _c2018. |
|
| 264 | 4 | _c©2018 | |
| 300 |
_a1 online resource (377 pages) : _billustrations |
||
| 336 |
_atext _2rdacontent |
||
| 337 |
_acomputer _2rdamedia |
||
| 338 |
_aonline resource _2rdacarrier |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 588 | _aDescription based on print version record. | ||
| 590 | _aElectronic reproduction. Ann Arbor, MI : ProQuest, 2018. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries. | ||
| 650 | 0 |
_aOpioid abuse _xChemotherapy. |
|
| 650 | 0 |
_aBuprenorphine _xTherapeutic use. |
|
| 655 | 4 | _aElectronic books. | |
| 700 | 1 |
_aRenner, John A., _cJr., _d1938- _eeditor. |
|
| 700 | 1 |
_aLevounis, Petros, _eeditor. |
|
| 700 | 1 |
_aLaRose, Anna T., _d1979- _eeditor. |
|
| 776 | 0 | 8 |
_iPrint version: _tOffice-based buprenorphine treatment of opioid use disorder. _bSecond edition. _dArlington, Virginia : American Psychiatric Association Publishing, c2018 _hxix, 375 pages _z9781615370832 _w2017039793 |
| 797 | 2 | _aProQuest (Firm) | |
| 856 | 4 | 0 |
_uhttps://ebookcentral.proquest.com/lib/bcsl-ebooks/detail.action?docID=5294185 _zClick to View |
| 999 |
_c762432 _d762432 |
||